- Home
- HTOO vs APLM Comparison
HTOO vs APLM Comparison
Compare HTOO & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTOO
- APLM
- Stock Information
- Founded
- HTOO 2020
- APLM 2016
- Country
- HTOO Ireland
- APLM United States
- Employees
- HTOO N/A
- APLM N/A
- Industry
- HTOO Natural Gas Distribution
- APLM Blank Checks
- Sector
- HTOO Utilities
- APLM Finance
- Exchange
- HTOO Nasdaq
- APLM Nasdaq
- Market Cap
- HTOO 7.7M
- APLM 6.1M
- IPO Year
- HTOO N/A
- APLM N/A
- Fundamental
- Price
- HTOO $4.50
- APLM $18.43
- Analyst Decision
- HTOO
- APLM
- Analyst Count
- HTOO 0
- APLM 0
- Target Price
- HTOO N/A
- APLM N/A
- AVG Volume (30 Days)
- HTOO 205.9K
- APLM 88.1K
- Earning Date
- HTOO 12-04-2023
- APLM 09-30-2025
- Dividend Yield
- HTOO N/A
- APLM N/A
- EPS Growth
- HTOO N/A
- APLM N/A
- EPS
- HTOO N/A
- APLM N/A
- Revenue
- HTOO $10,024,662.00
- APLM $198,000.00
- Revenue This Year
- HTOO $4,832.46
- APLM $415.15
- Revenue Next Year
- HTOO $81.82
- APLM N/A
- P/E Ratio
- HTOO N/A
- APLM N/A
- Revenue Growth
- HTOO 105.98
- APLM N/A
- 52 Week Low
- HTOO $3.41
- APLM $3.66
- 52 Week High
- HTOO $30.45
- APLM $35.98
- Technical
- Relative Strength Index (RSI)
- HTOO 52.47
- APLM 90.29
- Support Level
- HTOO $3.93
- APLM $3.66
- Resistance Level
- HTOO $4.45
- APLM $6.37
- Average True Range (ATR)
- HTOO 0.29
- APLM 1.65
- MACD
- HTOO 0.11
- APLM 1.20
- Stochastic Oscillator
- HTOO 70.00
- APLM 85.30
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.